Please login to the form below

A New Managing Director Appointed for Lighthouse Medical Communications US

Lucid Group boost their US operations with the appointment of Andy Willmer as Managing Director for Lighthouse Medical Communications

Lighthouse Medical Communications US (part of the Lucid Group) is pleased to announce the appointment of Andy Willmer to the position of Managing Director, leading the US operation and championing the growth of the group in the US market. Andy will lead the communications team in the delivery of exceptional medical education and disease understanding programmes, publications and communications planning, peer-to-peer medical communications and medical advocacy development. 

Andy brings an abundance of pharmaceutical, healthcare marketing and brand communications experience, having previously held senior positions within Pharmacia, Biovail and Roche, and most recently on the agency side with Ogilvy CommonHealth in the USA, where he held the position of General Manager, Medical Marketing.  

Lighthouse Medical Communications has experienced rapid growth since it was founded in 2014, predominately capitalising on US domestic business opportunities, with a view to expanding programmes on a global level. Lighthouse already has an impressive client roster and has been busy focusing on the needs of their clients, primarily working in womens’ health and novel biologic immuno-oncologic therapies.  

Dennis O’Brien (Lucid CEO and Co-Founder) commented, “Andy is a great fit with the team – and his history and experience in US and Global Pharma communications, both agency and client side, made him the ideal choice to head the Lighthouse Communications team in the US.  Andy shares our passion to create magical programmes that transform patients’ lives by improving outcomes”

“I’m thrilled to be leading such a smart and dynamic team. The Lighthouse (Lucid) approach of building strategic medical communications which can change lives is rewarding and where I want to be.” commented Andy. 

Andy can be contacted at: E:  
T:  +1 646 710 7736   M: +1 908 200 1145

12th October 2017



Company Details

Lucid Group Communications Limited

0345 0536671

Contact Website

First Floor, Jubilee House
Third Avenue
Globe Park

Latest content on this profile

My Lucid journey from PMW to Head of Medical
Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced and demanding industry, but one which offers enviable flexibility, variety and intellectual challenge. Leading agency Lucid Group prides itself on the many growth and development opportunities it offers its people. In this article, Katherine Duxbury, Lucid’s Head of Medical, reflects upon her own bespoke working journey over the past 12 years and explains how creativity, collaboration and a passion for science have led to a rewarding, stimulating and self-curated career.
Lucid Group Communications Limited
Listen, learn and lift off

Lucid Group Communications Limited
Launch excellence

Lucid Group Communications Limited
Meet The Lucid Group Talent Team
Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your career to the next level with us, you can be assured that you'll have a whole group of people here cheering you on.So, if you’re feeling stuck or unfulfilled in your current role and looking for a company that will provide the personal and career development you need, please check out our open roles here: contact one of our talent acquisition managers for a chat:Ellen Field Assoc CIPDElaine DowneyJon TurnerDaniel Newbury
Lucid Group Communications Limited
Extraordinary lives: advancing change in rare diseases (Part 2)

Lucid Group Communications Limited
Extraordinary lives: advancing change in rare diseases (Part 2)
In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so important?Because 300 million people worldwide are living with a rare disease. This means that, collectively, the number of people living with a rare disease is equivalent to the population of the world's third-largest country (USA).While we have come a long way since the inception of Rare Disease Day, there's still plenty of work to do.Part 2 of this series focuses on important topics including the role of technology and the opportunities it presents for the rare disease community. The panel also hold captivating insights on how the pandemic has impacted the use of related digital technologies, the role of gene therapy, the major challenges and successes for pharma companies in supporting the rare disease community over the last 13 years, and much, much more.If you’d like to know more about the work we do in rare diseases or would like advice on any healthcare communication challenges please get in touch with Clare Reynolds on LinkedIn or by email: clare.reynolds@wearelucidgroup.comAbout Lucid GroupFounded in 2007, Lucid Group is a global multi-capability healthcare consultancy with core expertise in medical strategy, healthcare communications, creative and brand strategy, motion, digital and technology, behaviour change, metrics, and data analytics.  We partner with the pharma and biotech industry, delivering life-transforming value with connected capabilities to create pioneering solutions that change behaviour, improve clinical practice and advance health outcomes.  Transforming lives. Always.
Lucid Group Communications Limited